{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:09:51Z","timestamp":1786122591500,"version":"build-2736575974"},"reference-count":47,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sao Paulo Research Foundation (FAPESP","award":["2003\/06870-5"],"award-info":[{"award-number":["2003\/06870-5"]}]},{"name":"Sao Paulo Research Foundation (FAPESP","award":["2016\/03025-2"],"award-info":[{"award-number":["2016\/03025-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Human T-cell lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with a broad spectrum of clinical manifestations. While most people living with HTLV-1 remain asymptomatic, a proportion develops severe conditions such as adult T-cell leukemia\/lymphoma or HTLV-1-associated myelopathy\/tropical spastic paraparesis. Increasing evidence also indicates that HTLV-1 infection is related to multiple systemic complications involving different organ systems (including neurological, pulmonary, dermatological, rheumatological, and ophthalmological disorders) and opportunistic infections. Given the growing recognition of these diverse manifestations, this review aims to compile and synthesize the scientific evidence regarding clinical manifestations, co-infections, opportunistic diseases, and complications related to HTLV-1 infection.<\/jats:p>","DOI":"10.1590\/s1678-9946202668054","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:46:56Z","timestamp":1786099616000},"source":"Crossref","is-referenced-by-count":0,"title":["HTLV-1-associated diseases: a systematic review"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8396-0263","authenticated-orcid":false,"given":"Rosa Maria Nascimento","family":"Marcusso","sequence":"first","affiliation":[{"name":"Instituto de Infectologia Emilio Ribas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-7587","authenticated-orcid":false,"given":"V\u00edctor \u00c2ngelo","family":"Folgosi","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-7973","authenticated-orcid":false,"given":"Augusto C\u00e9sar Penalva de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Instituto de Infectologia Emilio Ribas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-2559","authenticated-orcid":false,"given":"Jorge","family":"Casseb","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil; Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","article-title":"Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects","volume":"168","author":"Gessain A","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti FA","year":"2005","journal-title":"Oncogene"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.leu.2400956","article-title":"Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases","volume":"12","author":"Fouchard N","year":"1998","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/aid.2006.0140","article-title":"Clinical manifestations associated with HTLV type I infection: a cross-sectional study","volume":"23","author":"Caskey MF","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","article-title":"Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis","volume":"3","author":"Yamano Y","year":"2012","journal-title":"Front Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama T","year":"1977","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006281","article-title":"Human T-lymphotropic virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of indigenous Australians","volume":"12","author":"Einsiedel L","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"914498","DOI":"10.3389\/fimmu.2022.914498","article-title":"An overview of human T-lymphotropic virus type 1 lung injury","volume":"13","author":"Dias AR","year":"2022","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(21)00063-3","article-title":"Horizontal transmission of HTLV-1 causing uveitis","volume":"21","author":"Kamoi K","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12985-023-02135-7","article-title":"Prevalence and characteristics of HTLV-associated uveitis in patients from Bahia, an endemic area for HTLV \u2212 1 in Brazil","volume":"20","author":"Ozores DP","year":"2023","journal-title":"Virol J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"107058","DOI":"10.1016\/j.ijid.2024.107058","article-title":"Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease","volume":"145","author":"Bittencourt AL","year":"2024","journal-title":"Int J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.abd.2020.11.017","article-title":"Infectious dermatitis associated with HTLV-I: uncommon case in southern Brazil simulating refractory atopic dermatitis","volume":"97","author":"Garcia MC","year":"2022","journal-title":"An Bras Dermatol Port"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/v14071460","article-title":"Effect of HTLV-1 infection on the clinical course of patients with rheumatoid arthritis","volume":"14","author":"Umekita K","year":"2022","journal-title":"Viruses"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/aid.2015.0340","article-title":"Association of tuberculosis status with neurologic disease and immune response in HTLV-1 infection","volume":"33","author":"Souza A","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati A","year":"2009","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/ph16111546","article-title":"New perspectives about drug candidates targeting HTLV-1 and related diseases","volume":"16","author":"Silva MC","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/cid\/cis273","article-title":"Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases Observed in Bahia, Brazil","volume":"54","author":"Oliveira MF","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fmicb.2020.00152","article-title":"HTLV-1 infection and rheumatic diseases","volume":"11","author":"Umekita K","year":"2020","journal-title":"Front Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/v17070874","article-title":"Rheumatological manifestations in people living with human T-lymphotropic viruses 1 and 2 (HTLV-1 and HTLV-2) in Northern Brazil","volume":"17","author":"Tsukimata MY","year":"2025","journal-title":"Viruses"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/v14010100","article-title":"Does HTLV-1 infection show phenotypes found in Sj\u00f6gren\u2019s Syndrome?","volume":"14","author":"Nakamura H","year":"2022","journal-title":"Viruses"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12891-015-0773-1","article-title":"Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Nakamura H","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","article-title":"Inflammatory manifestations of HTLV-1 and their therapeutic options","volume":"10","author":"Martin F","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies","volume":"20","author":"Schierhout G","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"ref24","first-page":"100224","article-title":"Overview on coinfection of HTLV-1 and tuberculosis: mini-review","volume":"23","author":"Keikha M","year":"2021","journal-title":"J Clin Tuberc Mycobact Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12879-016-1428-z","article-title":"Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil","volume":"16","author":"Grassi MF","year":"2016","journal-title":"BMC Infect Dis"},{"key":"ref26","first-page":"12016","article-title":"HTLV-1 and co-infections","volume":"9","author":"Rosadas C","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e00078","DOI":"10.1128\/cmr.00078-21","article-title":"Clinical and public health implications of human T-lymphotropic virus type 1 infection","volume":"35","author":"Legrand N","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/pathogens12030492","article-title":"HAM\/TSP pathogenesis: the transmigration activity of HTLV-1-infected T cells into tissues","volume":"12","author":"Nakamura T","year":"2023","journal-title":"Pathogens"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s13365-020-00847-y","article-title":"Neurologic, clinical, and immunologic features in a cohort of HTLV-1 carriers with high proviral loads","volume":"26","author":"Ferraz SN","year":"2020","journal-title":"J Neurovirol"},{"key":"ref30","article-title":"Small cells lung epidermoid carcinoma in a HTLV1-infected patient: case report and literature review","volume":"63","author":"Dahy FE","year":"2021","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/v14040794","article-title":"Updates on HTLV-1 uveitis","volume":"14","author":"Kamoi K","year":"2022","journal-title":"Viruses"},{"key":"ref32","series-title":"Intraocular inflammation","first-page":"1197","volume-title":"HTLV-1 uveitis","author":"Kamoi K","year":"2016"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/exd.12007","article-title":"HTLV-1-associated infective dermatitis: updates on the pathogenesis","volume":"21","author":"McGill NK","year":"2012","journal-title":"Exp Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008241","article-title":"Clinicopathological aspects and proviral load of adulthood infective dermatitis associated with HTLV-1: comparison between juvenile and adulthood forms","volume":"14","author":"Souza LS","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-015-1002-0","article-title":"High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease","volume":"15","author":"Honarbakhsh S","year":"2015","journal-title":"BMC Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"00001","DOI":"10.1183\/23120541.00001-2019","article-title":"Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study","volume":"5","author":"Einsiedel L","year":"2019","journal-title":"ERJ Open Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-020-00543-z","article-title":"Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection","volume":"18","author":"Einsiedel L","year":"2021","journal-title":"Retrovirology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"ofu023","DOI":"10.1093\/ofid\/ofu023","article-title":"Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous Australians: results of a case-control study","volume":"1","author":"Einsiedel L","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"117979","DOI":"10.1016\/j.lfs.2020.117979","article-title":"HTLV-I induces lesions in the pulmonary system: a systematic review","volume":"256","author":"Normando VM","year":"2020","journal-title":"Life Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3389\/fmicb.2018.01879","article-title":"Human T lymphotropic virus and pulmonary diseases","volume":"9","author":"Dias AR","year":"2018","journal-title":"Front Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2169\/internalmedicine.2201-23","article-title":"Human T-cell lymphotropic virus type-1-associated bronchioloalveolar disorder with non-necrotizing granulomas: a case report and literature Review","volume":"63","author":"Kimura S","year":"2024","journal-title":"Intern Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3390\/pathogens10070895","article-title":"Clinical, radiological and functional characteristics of pulmonary diseases among HTLV-1 infected patients without prior active tuberculosis infection","volume":"10","author":"Cachay R","year":"2021","journal-title":"Pathogens"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/pathogens13070553","article-title":"High HTLV-1 proviral load predates and predicts HTLV-1-associated disease: literature review and the London Experience","volume":"13","author":"Taylor GP","year":"2024","journal-title":"Pathogens"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4067\/s0716-10182024000200307","article-title":"Mycobacterium tuberculosis y virus linfotropico humano, una co-infeccion fatal","volume":"41","author":"Morales J","year":"2024","journal-title":"Rev Chilena Infectol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"832430","DOI":"10.3389\/fmed.2022.832430","article-title":"Human T-cell lymphotropic virus type 1 and Strongyloides stercoralis co-infection: a systematic review and meta-analysis","volume":"9","author":"Ye L","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v16101616","article-title":"Current state of therapeutics for HTLV-1","volume":"16","author":"Wang TT","year":"2024","journal-title":"Viruses"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"101289","DOI":"10.1016\/j.coviro.2022.101289","article-title":"Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma","volume":"58","author":"Phillips AA","year":"2023","journal-title":"Curr Opin Virol"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652026000100608&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:47:04Z","timestamp":1786099624000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652026000100608&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":47,"alternative-id":["S0036-46652026000100608"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202668054","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e54"}}